Li et al. demonstrated that SNRPB facilitated HCC progression by modulating alternative splicing events, promoting the formation of AKT3-204 and LDHA-220 isoforms, which activated the Akt signaling pathway and aerobic glycolysis, respectively [20]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.